Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $27.50 Million |
|---|---|
| Enterprise Value | $27.27 Million |
| Earnings per Share | $-0.68 |
| Beta | 1.04 |
| Outstanding Shares | 10,199,999 |
| P/E Ratio | -5.22 |
|---|---|
| PEG | 99.81 |
| Price to Sales | 0.9 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.86 |
| Enterprise Value to EBIT | -3.78 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.08 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Medicure Inc. operates as a biopharmaceutical company dedicated to the research, development, and commercialization of therapeutic solutions for the cardiovascular market, primarily serving Canada and the United States. Among its key off...